Logo image of ALAVI.PA

ADVINI (ALAVI.PA) Stock Fundamental Analysis

EPA:ALAVI - Euronext Paris - Matif - FR0000053043 - Common Stock - Currency: EUR

12.5  -0.6 (-4.58%)

Fundamental Rating

2

Overall ALAVI gets a fundamental rating of 2 out of 10. We evaluated ALAVI against 24 industry peers in the Beverages industry. ALAVI may be in some trouble as it scores bad on both profitability and health. ALAVI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALAVI had negative earnings in the past year.
ALAVI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALAVI reported negative net income in multiple years.
Each year in the past 5 years ALAVI had a positive operating cash flow.
ALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M 40M

1.2 Ratios

With a Return On Assets value of -3.19%, ALAVI is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
ALAVI has a Return On Equity of -17.22%. This is amonst the worse of the industry: ALAVI underperforms 91.67% of its industry peers.
Industry RankSector Rank
ROA -3.19%
ROE -17.22%
ROIC N/A
ROA(3y)-0.64%
ROA(5y)-0.43%
ROE(3y)-3.94%
ROE(5y)-2.63%
ROIC(3y)N/A
ROIC(5y)N/A
ALAVI.PA Yearly ROA, ROE, ROICALAVI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10

1.3 Margins

ALAVI has a Gross Margin of 35.70%. This is in the lower half of the industry: ALAVI underperforms 75.00% of its industry peers.
In the last couple of years the Gross Margin of ALAVI has grown nicely.
ALAVI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.37%
GM growth 5Y9.57%
ALAVI.PA Yearly Profit, Operating, Gross MarginsALAVI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

ALAVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALAVI has been reduced compared to 1 year ago.
The number of shares outstanding for ALAVI has been reduced compared to 5 years ago.
ALAVI has a worse debt/assets ratio than last year.
ALAVI.PA Yearly Shares OutstandingALAVI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
ALAVI.PA Yearly Total Debt VS Total AssetsALAVI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of 0.81, we must say that ALAVI is in the distress zone and has some risk of bankruptcy.
ALAVI has a worse Altman-Z score (0.81) than 91.67% of its industry peers.
The Debt to FCF ratio of ALAVI is 38.51, which is on the high side as it means it would take ALAVI, 38.51 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 38.51, ALAVI is doing worse than 62.50% of the companies in the same industry.
ALAVI has a Debt/Equity ratio of 2.65. This is a high value indicating a heavy dependency on external financing.
ALAVI's Debt to Equity ratio of 2.65 is on the low side compared to the rest of the industry. ALAVI is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 38.51
Altman-Z 0.81
ROIC/WACCN/A
WACC4.78%
ALAVI.PA Yearly LT Debt VS Equity VS FCFALAVI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.91 indicates that ALAVI may have some problems paying its short term obligations.
With a Current ratio value of 0.91, ALAVI is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
A Quick Ratio of 0.30 indicates that ALAVI may have some problems paying its short term obligations.
ALAVI has a Quick ratio of 0.30. This is amonst the worse of the industry: ALAVI underperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.3
ALAVI.PA Yearly Current Assets VS Current LiabilitesALAVI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

ALAVI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -423.08%.
The Revenue has decreased by -4.22% in the past year.
The Revenue has been growing slightly by 2.21% on average over the past years.
EPS 1Y (TTM)-423.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.03%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y4.98%
Revenue growth 5Y2.21%
Sales Q2Q%-1.95%

3.2 Future

Based on estimates for the next years, ALAVI will show a very strong growth in Earnings Per Share. The EPS will grow by 50.76% on average per year.
Based on estimates for the next years, ALAVI will show a small growth in Revenue. The Revenue will grow by 0.70% on average per year.
EPS Next Y-24.26%
EPS Next 2Y50.49%
EPS Next 3Y50.76%
EPS Next 5YN/A
Revenue Next Year-3.21%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.7%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALAVI.PA Yearly Revenue VS EstimatesALAVI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
ALAVI.PA Yearly EPS VS EstimatesALAVI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALAVI. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 67.42 indicates a quite expensive valuation of ALAVI.
Based on the Price/Forward Earnings ratio, ALAVI is valued more expensive than 87.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.81. ALAVI is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 67.42
ALAVI.PA Price Earnings VS Forward Price EarningsALAVI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

ALAVI's Enterprise Value to EBITDA ratio is in line with the industry average.
83.33% of the companies in the same industry are more expensive than ALAVI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.96
EV/EBITDA 11.04
ALAVI.PA Per share dataALAVI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

A more expensive valuation may be justified as ALAVI's earnings are expected to grow with 50.76% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.49%
EPS Next 3Y50.76%

More info and screens

3

5. Dividend

5.1 Amount

ALAVI has a Yearly Dividend Yield of 2.08%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.88, ALAVI is paying slightly less dividend.
ALAVI's Dividend Yield is comparable with the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

The dividend of ALAVI is nicely growing with an annual growth rate of 13.49%!
Dividend Growth(5Y)13.49%
Div Incr Years0
Div Non Decr Years0
ALAVI.PA Yearly Dividends per shareALAVI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.1 0.2 0.3

5.3 Sustainability

The earnings of ALAVI are negative and hence is the payout ratio. ALAVI will probably not be able to sustain this dividend level.
ALAVI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-10.64%
EPS Next 2Y50.49%
EPS Next 3Y50.76%
ALAVI.PA Yearly Income VS Free CF VS DividendALAVI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

More info and screens

ADVINI

EPA:ALAVI (5/2/2025, 7:00:00 PM)

12.5

-0.6 (-4.58%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)07-24 2025-07-24
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners23.83%
Ins Owner ChangeN/A
Market Cap49.25M
Analysts82
Price Target17.75 (42%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend0.35
Dividend Growth(5Y)13.49%
DP-10.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-45.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 67.42
P/S 0.17
P/FCF 8.96
P/OCF 3.99
P/B 0.68
P/tB 1.57
EV/EBITDA 11.04
EPS(TTM)-3.3
EYN/A
EPS(NY)0.19
Fwd EY1.48%
FCF(TTM)1.39
FCFY11.16%
OCF(TTM)3.13
OCFY25.06%
SpS72.1
BVpS18.41
TBVpS7.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.19%
ROE -17.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.7%
FCFM 1.93%
ROA(3y)-0.64%
ROA(5y)-0.43%
ROE(3y)-3.94%
ROE(5y)-2.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.37%
GM growth 5Y9.57%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 38.51
Debt/EBITDA 14.48
Cap/Depr 43%
Cap/Sales 2.41%
Interest Coverage N/A
Cash Conversion 92.95%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.3
Altman-Z 0.81
F-Score6
WACC4.78%
ROIC/WACCN/A
Cap/Depr(3y)73.75%
Cap/Depr(5y)75%
Cap/Sales(3y)3.53%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-423.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.03%
EPS Next Y-24.26%
EPS Next 2Y50.49%
EPS Next 3Y50.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y4.98%
Revenue growth 5Y2.21%
Sales Q2Q%-1.95%
Revenue Next Year-3.21%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.7%
Revenue Next 5YN/A
EBIT growth 1Y-164.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year281.13%
EBIT Next 3Y74.8%
EBIT Next 5YN/A
FCF growth 1Y-44.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.82%
OCF growth 3Y-67.32%
OCF growth 5Y-52.31%